IP Library Patent Application 19216245
Patent Application
App. No. 19/216,245

DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/216,245
Abstract

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, e.g., in the treatment of a mental health disease or disorder.

Claims (24)

1 . A compound of formula (I-A):

or a pharmaceutically acceptable salt thereof, wherein:

R 1 is independently at each position -hydrogen, —C 1 -C 6 alkyl, or —C 1 -C 6 haloalkyl;

R 2 and R 3 are each independently -hydrogen, —C 1 -C 6 alkyl, —C 1 -C 6 haloalkyl, -halogen, -cyano, —OR 1 or —SR 1 , wherein at least one of R 2 and R 3 is -hydrogen;

R 4 , R 5 , and R 6 are each independently -hydrogen, —C 1 -C 6 alkyl, —C 1 -C 6 haloalkyl, -halogen, -cyano, —OR 1 , —SR 1 , —O(C═O)(R 12 ), or —NH(C═O)(R 12 ), wherein R 12 is C 1 -C 6 alkyl; and

n is 0, 1, 2, or 3.

2 . The compound of claim 1 , wherein R 1 is —C 1 -C 6 alkyl.

3 . The compound of claim 1 , wherein R 1 is -methyl, -ethyl, -propyl, or -isopropyl.

4 . The compound of claim 1 , wherein R 1 is -methyl.

5 . The compound of claim 1 , wherein R 2 is -hydrogen, -halo, or —C 1 -C 6 alkyl.

6 . The compound of claim 1 , wherein R 3 is -hydrogen, -halo, or —C 1 -C 6 alkyl.

7 . The compound of claim 1 , wherein R 2 is -halogen and R 3 is -hydrogen.

8 . The compound of claim 1 , wherein R 2 is -hydrogen and R 3 is -halogen.

9 . The compound of claim 1 , wherein R 2 and R 3 are each -hydrogen.

10 . The compound of claim 1 , wherein R 4 , R 5 and R 6 are each independently -hydrogen, —C 1 -C 6 alkyl, or -halogen.

11 . The compound of claim 1 , wherein R 4 , R 5 and R 6 are each independently -hydrogen, -methyl, or -halogen.

12 . The compound of claim 1 , wherein n is 1.

13 . The compound of claim 1 , wherein n is 2.

14 . The compound of claim 1 , wherein the compound is:

a pharmaceutically acceptable salt thereof.

15 . The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

16 . The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2026
From: SHORT, GLENN; PERNI, ROBERT B.; DIFRANCESCO, BENJAMIN ROBERT; KHAN, TANWEER A.
To: ATAI THERAPEUTICS, INC.
Reel/Frame 075803/0888 →